fbpx
Athena Care
Spravato (Esketamine)

Spravato (Esketamine)

Athena Care believes in utilizing all evidence and research based treatment options to better serve our clients, including newer medications and modalities of treatment.

That is why we have taken the steps necessary to become one of the first certified Spravato treatment centers in the greater Nashville area.

On March 5, 2019, the U.S. Food and Drug Administration (FDA) approved Spravato™ (esketamine) nasal spray. Spravato is a prescription medicine, used along with an antidepressant taken by mouth, for treatment-resistant depression (TRD) in adults. Additionally, is approved for the quick resolution of major depression with suicidal ideation (MDSI). Spravato is the latest advancement in over a decade approved by the FDA to treat TRD.

What is Spravato?

Spravato is brand name for esketamine produced by Janssen Pharmaceutical Company of Johnson & Johnson. Spravato is only available in a nasal spray form, and only approved by the FDA for treating patients suffering from treatment-resistant depression (TRD).

Is Spravato right for me?

Spravato is FDA approved exclusively for adults suffering from Treatment Resistant Depression (TRD).  Patients suffering from depression are typically considered treat-resistant if they have not sufficiently responded to at least two different antidepressants of adequate dose and duration in the current depressive episode. To determine if Spravato is right for you, contact our team at Athena Care to discuss your specific situation and treatment options.

Where do I get Spravato?

Although Spravato esketamine is administered as a nasal spray, people will not be permitted to purchase it for home use. To guard against abuse, patients will need to use Spravato under medical supervision at a clinic or doctor’s office that has been certified by the maker of Spravato as an authorized provider. Athena Care is a certified authorized provider of Spravato.

Do I qualify for treatment with Spravato?

Spravato is not for everyone.  Spravato is only approved for adults suffering from Treatment Resistant Depression (TRD).  To determine if you qualify, your doctor will work with you on the qualification process. Contact us to discuss your specific situation, review the qualification requirements, and learn about treatment options.

Does my insurance cover Spravato?

Spravato was approved by the FDA in March 2019.  Most insurance providers are now offering coverage for qualified patients.  As a first step, contact Athena Care and our team will help you understand your insurance coverage and other possible affordability options. Or you may fill in our insurance verification form. These forms are included at the bottom of this page.

Where do I go to get Spravato treatments?

Spravato treatments are administered under the direct supervision of a medical doctor and the supporting medical staff at Athena Care. Spravato is not available for use outside the medical clinic.

What are the potential side effects and risks of Spravato?

Contact us to learn more about Spravato.  For additional information about Spravato from Janssen Pharmaceuticals, Inc., the maker of Spravato, visit www.spravato.com

How can I get more information about Spravato?

Call Athena Care at (615) 320-1155 or fill out the appointment form below.